These differences in the composition of the plaques have led to the classification of FDD and FBD as distinct Alzheimer’s disease-related dementias (ADRD) and to the conclusion that ITM2B mutations cause accumulation of amyloidogenic peptides aggregates, which lead to neuronal damage and dementia. Here, ITM2B is linked to dementia.